Symbol="ACRV"
AssetType="Common Stock"
Name="Acrivon Therapeutics Inc. Common Stock"
Description="Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of precision cancer medicines. The company is headquartered in Watertown, Massachusetts."
CIK="1781174"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="273198000"
EBITDA="-39394000"
PERatio="None"
PEGRatio="None"
BookValue="7.32"
DividendPerShare="0"
DividendYield="0"
EPS="-1.64"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.142"
ReturnOnEquityTTM="-0.283"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="22.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-9.39"
Beta="None"
num_52WeekHigh="25.47"
num_52WeekLow="8.06"
num_50DayMovingAverage="12.52"
num_200DayMovingAverage="13.89"
SharesOutstanding="21926000"
DividendDate="None"
ExDividendDate="None"
symbol="ACRV"
open="12.60"
high="12.60"
low="11.90"
price="11.98"
volume="6400.00"
latest_trading_day="2023-08-02"
previous_close="12.46"
change="-0.48"
change_percent="-3.8523%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="81"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="53544"
Change_recent_avg="-0.1"
Delta_recent_avg="1.11"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="-1.0"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="147"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_negative_thumbnail_id_2="1090"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0123.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="963"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
